References
[1]. Arunachalam, N., Tana, S., Espino, F., Kittagong, P.,
Abeyewickreme, W., Wai, K., Tyagi, B., Kroeger, A.,
Sommerfold, J., &Petzold, M. (2010). “Eco-bio-social
determinants of dengue vector breeding: A multicountry
study in urban and periurban Asia”. Bulletin Of The World
Health Organization, Vol. 88, No. 3, pp. 173-184.
doi:10.2471/ BLT.09.067892
[2]. Assir, M. Z. K., Kamran, U., Ahmed, H. I., Bashir, S.,
Mansoor, H., Anees, S. B., & Akram, J. (2013). “Effectiveness
of platelet transfusion in dengue fever: A randomized
controlled trial”. Transfusion Medicine and Hemotherapy,
Vol. 40, No. 5, pp. 362-368. doi:10.1159/000354837.
3]. Centers for disease control and prevention. (2013).
CDC - DENV-1-4 Real-Time RT-PCR Assay. Retrieved from
http://www.cdc.gov/dengue/clinicalLab/realTime.html
[4]. Duber,H. C., & Kelly, S.M. (2013). “Febrile illness in a
young traveler: Dengue fever and its complications.” The
Journal of Emergency Medicine. Vol. 45, No. 4, pp. 526-
529. doi:10.1016/j.jemermed.2013.03.021
[5]. Fatima, M., Salim, M., & Farooq, A. (2012). “Outbreak of
Dengue fever in Lahore: study of risk factors.” Journal of Ayub
Medical College Abbottabad, Vol. 24, No. 2, pp. 99-101.
Retrieved from http://www.ayubmed.edu.pk/JAMC/24-
2/Fatima.pdf.
[6]. Gibbons, R.V. & Vaughn, D. W. (2002). “Dengue: an
escalating problem.” British Medical Journal, Vol. 324, No.
7353, pp. 1563-1566. doi:10.1136/bmj.324.7353.1563.
[7]. Girimont, T.M. (2010). “Dengue disease.” American
Association of Occupational Health Nurses, Vol. 58, No. 10,
pp. 448. doi:10.3928/08910162-2010092-03.
[8]. Gomez-Dantes, H., &Willoquet, J. R. (2009). “Dengue in
the Americas: Challenges for prevention and control.”
Cadernos de SaudePublica, Vol. 25, No. 1, pp. 519-531.
Retrieved from http://dx.doi.org/10.1590/S0102-
311X2009001300003
[9]. Jahan, F. (2011). “Dengue fever (DF) in Pakistan.” Jahan
Asia Pacific Family Medicine, Vol. 10, No. 1, pp. 1-4. doi:
10.1186/1447-056X-10-1.
[10].Joseph,B.,&Nair, V.M . (2013) .
“Ethanopharmacological and phytochemical aspects of
Ocimum sanctum Linn: The elixir of life.” British Journal of
Pharmaceutical Research, Vol. 3, No. 2, pp. 273-292.
[11]. Kashyap, C. P., Ranjeet, K., Vikrant, A., &Vipin, K.
(2011) . “Therapeutic potency of Ocimum
kilimandscharic umguerke. ” Global Journal of
Pharmacology, Vol. 5, No. 3, pp. 191-200. Retrieved from
http ://idosi.org/gjp/5(3)11/14.pdf.
[12]. Pye, J. (2012). “Raising awareness of dengue fever.”
Nursing Standards, Vol. 26, No. 51, pp. 53-56. Retrieved
from http://dx.doi.org/10.7748/ns2012.08.26.51.53.c9244
[13]. Queensland Dengue Management Plan. (2011).
Retrieved from https://docs.google.com/viewer?a=v&q
cache:fPLQQu_KiQJ:www.health.qld.gov.au/dengue/doc
uments/denguemgtplan.pdf+Queensland+Dengue+M
anagement+Plan,+2011&hl=en&pid=bl&srcid=ADGEE
SgcYR5mBUOciIH4Lu22e2hZvpZ8LBbqUpVJO1yXAKEZ0Ws
MCKMTS7GDyxs9tPV_rQinvvCllH0ReiREriuuEVQkKku_YOPX6
0ybNs5MEBg7P9GxzIKBOid4RxMT2HfIIA7XASs&sig=AHIEtbT
sfkfQFI2WCtpTknYrV7At3boZTA
[14]. Sajid, A., Ikram, A., & Ahmed, A. (2012). “Dengue
fever outbreak 2011: Clinical profile of children presenting
at Madina teaching hospital Faisalabad.” Journal of
University Medical & Dental College, Vol. 3, No. 1, pp. 42-
47. Retrieved from http://jumdc.tuf.edu.pk/articles/volume-
3/no-1/JUMDC-8_Dengue.pdf
[15]. Simmons , C. P., Farrar, J. J., VinhChau, N. V., & Wills, B.
(2012). “Dengue”. New England Journal of Medicine, Vol.
366, pp. 1423-32. doi:10.1056/NEJMra1110265.
[16]. Sulehri, M. A., Hussain, R., & Gill, N. I. (2012). “Dengue
fever its diagnosis, treatment, prevention and control.”
A.P.M.C, Vol. 6, No. 1, pp. 22-27.
[17]. Teng, T. B. (2001). “New initiatives in Dengue Control in Singapore.” Dengue Bulletin, Vol. 25, pp. 1-6.
[18]. Thomas, S. J., & Endy, T. P. (2011). “Vaccines for the
prevention of dengue.” Human Vaccines, Vol. 7, No. 6, pp.
674-684. doi:10.4161/hv.7.6.14985.
[19]. WHO-EMRO. (2014). Dengue fever disease outbreak
news, Gloabal Alert and Response.